ABVC BioPharma, Inc.: 10-Q filed 2017-08-21
What ABVC BioPharma, Inc. reported in its quarterly report filed 2017-08-21 (fiscal Q3 2017): 22 published measures, 63 facts as tagged in accession 0001213900-17-009012.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2017-08-21
- Fiscal period
- fiscal Q3 2017
- Accession
- 0001213900-17-009012 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ABVC BioPharma, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 8,053 | USD | |
| At 2016-09-30 | 177,352 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 1,056,130 | USD | |
| At 2016-09-30 | 6,556,470 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | -1,048,077 | USD | |
| At 2016-09-30 | -6,379,118 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 8,053 | USD | |
| At 2016-10-01 | 173,537 | USD | |
| At 2016-09-30 | 173,537 | USD | |
| At 2016-06-30 | 84,904 | USD | |
| At 2015-09-30 | 994,830 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -127,879 | USD | 91 |
| 2016-10-02 to 2017-06-30 | -524,887 | USD | 272 |
| 2016-04-01 to 2016-06-30 | -293,237 | USD | 91 |
| 2015-10-01 to 2016-06-30 | -10,353,605 | USD | 274 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 90,000 | USD | 91 |
| 2016-10-02 to 2017-06-30 | 160,000 | USD | 272 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | -11,848,288 | USD | |
| At 2016-09-30 | -11,323,401 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-10-02 to 2017-06-30 | 830 | USD | 272 |
| 2016-04-01 to 2016-06-30 | 836 | USD | 91 |
| 2015-10-01 to 2016-06-30 | 836 | USD | 274 |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 2,552 | USD | 91 |
| 2016-10-02 to 2017-06-30 | 5,928 | USD | 272 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -99,479 | USD | 91 |
| 2016-10-02 to 2017-06-30 | -476,706 | USD | 272 |
| 2016-04-01 to 2016-06-30 | -289,098 | USD | 91 |
| 2015-10-01 to 2016-06-30 | -10,349,518 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 8,053 | USD | |
| At 2016-09-30 | 173,537 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 28,500 | USD | 91 |
| 2016-10-02 to 2017-06-30 | 47,500 | USD | 272 |
| 2016-04-01 to 2016-06-30 | 3,753 | USD | 91 |
| 2015-10-01 to 2016-06-30 | 3,753 | USD | 274 |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 189,479 | USD | 91 |
| 2016-10-02 to 2017-06-30 | 636,706 | USD | 272 |
| 2016-04-01 to 2016-06-30 | 289,098 | USD | 91 |
| 2015-10-01 to 2016-06-30 | 10,349,486 | USD | 274 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 90,000 | USD | 91 |
| 2016-10-02 to 2017-06-30 | 160,000 | USD | 272 |
| 2015-10-01 to 2016-06-30 | -32 | USD | 274 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-10-01 to 2016-06-30 | 32 | USD | 274 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 169,427 | USD | 91 |
| 2016-10-02 to 2017-06-30 | 562,930 | USD | 272 |
| 2016-04-01 to 2016-06-30 | 289,098 | USD | 91 |
| 2015-10-01 to 2016-06-30 | 349,486 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 17,500 | USD | 91 |
| 2016-10-02 to 2017-06-30 | 67,848 | USD | 272 |
| 2015-10-01 to 2016-06-30 | 10,000,000 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 213,746,647 | shares | |
| At 2016-09-30 | 210,821,647 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 10,586,464 | USD | |
| At 2016-09-30 | 4,733,461 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -127,879 | USD | 91 |
| 2016-10-02 to 2017-06-30 | -524,057 | USD | 272 |
| 2016-04-01 to 2016-06-30 | -292,401 | USD | 91 |
| 2015-10-01 to 2016-06-30 | -10,352,769 | USD | 274 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -28,400 | USD | 91 |
| 2016-10-02 to 2017-06-30 | -47,351 | USD | 272 |
| 2016-04-01 to 2016-06-30 | -3,303 | USD | 91 |
| 2015-10-01 to 2016-06-30 | -3,251 | USD | 274 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-10-02 to 2017-06-30 | -17,540 | USD | 272 |
| 2015-10-01 to 2016-06-30 | 11,446 | USD | 274 |
Inspect the source
- Entity
- ABVC BioPharma, Inc. / CIK 0001173313
- Captured
- 2026-09-19T11:16:49.109Z
- SEC response SHA-256
a42942c118304cb578665c27ca73d827a17f370dd57a31742c919c9b41b25c34
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001173313.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))